Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 3, 2009, Pages 745-754

  Carlo Stella, N ^a   Bozzini, S ^a   De Silvestri, A ^b   Sbarsi, I ^b   Pizzochero, C ^b   Lorusso, L ^c   Martinetti, M ^b   Cuccia, Mariaclara ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Mellino Meilini Hospital   (Italy)

Author keywords

Chronic fatigue syndrome; Haplotypes; HLA; Linkage disequilibrium; RAGE

Indexed keywords

HLA DR ANTIGEN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GLYCATION; HAPLOTYPE; HUMAN; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; SCHOOL CHILD;

CASE-CONTROL STUDIES; FATIGUE SYNDROME, CHRONIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; ITALY; LINKAGE DISEQUILIBRIUM; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC; RISK ASSESSMENT; RISK FACTORS;

EID: 70350543486     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200320     Document Type: Article

References (29)

1. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001; 108:949-955
2. Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999; 84:489-497 (Pubitemid 29138585)
3. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005; 15:16-28. (Pubitemid 41417992)
4. Falcone C, Campo I, Emanuele E, et al. -374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis. Clin Chim Acta 2005; 354:111-116 (Pubitemid 40320680)
5. Takeuchi M, Yamagishi S. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease. Curr Pharm Des 2008; 14:973-978 (Pubitemid 351753285)
6. Hudson B, Stickland MH, Futers S, Grant PJ. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001; 50:1505-1511 (Pubitemid 32500186)
7. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108:387-389 (Pubitemid 18163061)
8. Kerr JR, Barah F, Mattey DL, et al. Circulating tumour necrosis factor-alpha and interferon gamma are detectable during acute and convalescent parvovirus B 19 infection and are associated with prolonged and chronic fatigue. J Gen Virol 2001; 82: 3011-3019 (Pubitemid 33107516)
9. Devanur LD, Kerr JR. Chronic fatigue syndrome. J Clin Virol 2006; 37:139-150
10. Lane RJ, Soteriou BA, Zhang H, Archard LC. Enterovirus related metabolic myopathy: a postviral fatigue syndrome. J Neurol Neurosurg Psychiatry 2003; 74:1382-1386 (Pubitemid 37193948)
11. Natelson BH, Haghighi MH, Ponzio NM. Evidence for the presence of immune dysfunction in chronic fatigue syndrome. Clin Diagn Lab Immunol 2002; 9: 747-752 (Pubitemid 34773873)
12. Carlo-Stella N, Badulli C, De Silvestri A, et al. A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 2006; 24:179-182 (Pubitemid 43826869)
13. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121: 953-959
14. Klein J, Sato A. The HLA system. First of two parts. NEJM 2000; 343:702-709
15. Hill AVS. The immunogenetics of human infectious diseases. Ann Rev Immunol 1998; 16:593-617.
16. Klein J, Sato A. The HLA system. Second of two parts. NEJM 2000; 343:782-786
17. Underhill JA, Mahalingam M, Peakman M, Wessely S. Lack of association between HLA genotype and chronic fatigue syndrome. Eur J Immunogenet 2001; 28:425-428 (Pubitemid 32575056)
18. Smith J, Fritz EL, Kerr JR, Cleare AJ, Wessely S, Mattey DL. Association of chronic fatigue syndrome with human leukocyte antigen class II alleles. J Clin Pathol 2005; 58:860-863 (Pubitemid 41113395)
19. Laki J, Kiszel P, Vatay A, et al. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients. Mol Immunol 2007; 44:648-655
20. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39:225-235
21. Terwilliger J, Ott J. Handbook for Human Genetic Linkage. Johns Hopkins University Press, 1994 Baltimore.
22. Asti M, Martinetti M, Zavaglia C, et al. Human leukocyte antigen class II and III alleles and severity of Hepatitis C virus-related chronic liver disease. Hepatology 1999; 29:1272-1279 (Pubitemid 29168765)
23. Mangia A, Gentile R, Cascavilla I, et al. HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J Hepatol 1999; 30:984-9. (Pubitemid 29278740)
24. Martinetti M, Pacati I, Cuccia M, et al. Hierarchy of baby-linked immunogenetic risk factors in the vertical transmission of hepatitis C virus. Int J Immunopathol Pharmacol 2006; 19:369-378 (Pubitemid 44181959)
25. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003; 9:641-644
26. Tazi-Ahnini R, Timms JM, Cox A, Wilson AG. Identification of novel single nucleotide polymorphisms within the NOTCH4 gene and determination of association with MHC alleles. Eur J Immunogenetics 2003; 30:101-105 (Pubitemid 36408297)
27. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nature Gen 2005; 37:357-364 (Pubitemid 40490485)
28. Falcone C, Campo I, Emanuele E, et al. Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. Int J Mol Med 2004; 14:1061-1064
29. Falcone C, Geroldi D, Buzzi MP, et al. The -374T/A RAGE polymorphism protects against future cardiac events in non-diabetic patients with coronary artery disease. Arch Med Res 2008; 39:320-325